News and Trends 15 Dec 2022
Solve Therapeutics launches to tackle cancer
…reviewing other potential in-licensing opportunities as well as performing in-house antibody discovery research. The company’s focus is on the development of novel mAbs, antibody drug conjugates incorporating next-generation linker and…
